Prospective pooled analysis of six phase III trials investigating duration of adjuvant oxaliplatin-based therapy (3 versus 6 months) for patients with stage III colon cancer: The IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration (Alliance)
- Citation:
- J Clin Oncol vol 35 (18 suppl) abstr LBA1
- Meeting Instance:
- ASCO 2017
- Year:
- 2017
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Parents:
- None
- Children:
- 2805
- Pharmas:
- Pfizer
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Qian Shi Alberto Sobrero Anthony Shields Takayuki Yoshino TBN Julien Taieb Ioannis Souglakos Roberto Labianca Jeffrey Meyerhardt Franck Bonnetain Toshiaki Watanabe Ioannis Mpoukovinas Lindsay Renfro Axel Grothey Donna Niedzwiecki Valter Torri Thierry Andre Dan Sargent
- Networks:
- CORA, LAPS-MA036, LAPS-MN026
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-80702
- Phases:
- 3
- Keywords: